Snoasis Medical is a leader in placental based products with 48 scientific and clinical publications including Randomized Controlled Trials (RCTs) published.
Stay tuned as we continue to update this section with the latest additions to the growing body of evidence demonstrating that BioXclude is the best option for your patients.
Data Always Wins: BioXclude's Antimicrobial Properties Unlike Any Other
It pleases me to share new cool scientific research comparing amnion-chorion membrane (ACM) products BioXclude®, AlloGuide™ GF and AmnioExcite™ in a well-established bacterial inhibition assay that evaluates ability to prevent the growth of Streptococcus gordonii, a pathogenic strain of bacteria associated with periodontal disease.
November BioXclude Case of the Month by Dr. Anthony Del Vecchio
Today we are pleased to showcase, Dr. Del Vecchio’s open window sinus lift utilizing BioXclude.
New BioXclude Publication - Sandwich Technique for Enhanced Periodontal Regenerative Therapy
I am pleased to share a new BioXclude article recently published in Clinical Advances in Periodontics.
July BioXclude Case of the Month by Dr. Tyler Borg
Today we are pleased to showcase this nasopalatine duct cyst repair case from Dr. Tyler Borg.
April Case of the Month by Dr. Nicholas Gadler
Today we are pleased to showcase, what Dr. Gadler considered his “Most Challenging BioXclude Case” to date
March Case of the Month by Dr. Michael Sonick
Today we are pleased to showcase the Esthetic Rehabilitation with (SFOT) Surgical Facilitated Orthodontic Therapy by Dr. Michael Sonick
New BioXclude Publication, Open Wound Approach for Horizontal Ridge Augmentation BioXclude + Initiation of Prospective Randomized Clinical Study to Confirm Observed Results
Clinical data challenging the concept that predictable and successful horizontal ridge augmentation requires primary closure when using BioXclude.
BioXclude Best Case Winner: General Dentistry & Implantology
This spring we requested your best cases, and today I am both honored and excited to share with you our winner for the best case in the general dentistry and implantology category, Dr. Dean Licenblat.
NEW BioXclude Poster, Antimicrobial With & Without Nicotine Against Four Dental Pathogens |2020 Academy of Osseointegration
We are excited to share this poster by Yusuke Hamada, DDS, MSD presented at the Academy of Osseointegration Annual Meeting: Antimicrobial Effects of Dehydrated Human Amnion-Chorion Membranes Against Dental Pathogens With and Without the Effect of Nicotine: In Vitro.
NEW BioXclude® Publication Demonstrates Antibacterial Properties of Membrane
I am pleased to share our second publication, appearing in the prestigious journal Scientific Reports (4.6 Impact Factor), documenting the antibacterial properties of our Purion® processed human deepithelialized amnion-chorion membrane (BioXclude®)
New Socket Preservation Educational Brochure - The New Standard In Patient-Centered Outcomes
You already know BioXclude® is different and awesome, which is why you won’t be surprised to hear that its use in socket preservation is leading to incredible results! The healing at 3-4 days is unprecedented.
BioXclude “Kills” S. Gordonii w/ Histone H2A/H2B, Cathelicidin, Lactoferrin and Lysozyme - New Poster Presentation, Update from AAP
Hot News! I am pleased to share an exciting poster presentation on BioXclude® from the on-going annual American Academy of Periodontology meeting.
BioXclude Best Case Winner: Oral & Maxillofacial Surgery
We requested your best cases, and today I am both honored and excited to share with you our winner for the best case in the oral & maxillofacial surgery category, Michael J. Hartman, DMD, MD.
BioXclude Best Case Winner: Periodontology
This spring we requested your best cases, and today I am both honored and excited to share with you our winner for best case in the periodontology category, Robert J. Miller, DMD.
Have You Had Negative Encounters With Exposed Membranes? Amazing Post-Operative Healing In Only 3-4 Days - BioXclude® - The New Standard In Patient-Centered Benefits
Antimicrobial properties are yet another reason why primary closure is not required for predictable, successful outcomes in many types of guided bone regeneration procedures.
Does Your Membrane Have Antimicrobial Properties? BioXclude® Prevents Proliferation Of Oral Pathogens In-Vitro - New Publication
In this study, ddACM (BioXclude) prevented growth of all three bacterial strains: A.a., S.m., and S.o., performing as well as Tetracycline in this essay.
Hamada Sandwich Technique
Introducing the BioXclude® 'Sandwich' Technique - A new powerful regenerative therapy for enhanced healing!
Recession + Incredible Adjunct with Traditional Soft Tissue Grafts
Why is it reasonable to refer to BioXclude® dehydrated human deepithelialized amnion-chorion membrane (ddACM) as “Nature’s Duct Tape”?